# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-018766
Filing Date
2024-02-22
Accepted
2024-02-22 16:10:48
Documents
101
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | dvax-20231231.htm iXBRL | 10-K | 3677015
2 | EX-21.1 | dvax-ex21_1.htm | EX-21.1 | 2994
3 | EX-23.1 | dvax-ex23_1.htm | EX-23.1 | 7680
4 | EX-31.1 | dvax-ex31_1.htm | EX-31.1 | 24013
5 | EX-31.2 | dvax-ex31_2.htm | EX-31.2 | 24006
6 | EX-32.1 | dvax-ex32_1.htm | EX-32.1 | 8442
7 | EX-32.2 | dvax-ex32_2.htm | EX-32.2 | 8392
8 | EX-97.1 | dvax-ex97_1.htm | EX-97.1 | 55062
9 | GRAPHIC | img25882306_0.jpg | GRAPHIC | 278743
| Complete submission text file | 0000950170-24-018766.txt |  | 16048147

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | dvax-20231231.xsd | EX-101.SCH | 2258135
103 | EXTRACTED XBRL INSTANCE DOCUMENT | dvax-20231231_htm.xml | XML | 3025942

Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34207 | Film No.: 24664824
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)